Free Trial

Afya Limited (NASDAQ:AFYA) Shares Sold by Perpetual Ltd

Afya logo with Consumer Discretionary background

Perpetual Ltd trimmed its holdings in shares of Afya Limited (NASDAQ:AFYA - Free Report) by 29.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 448,940 shares of the company's stock after selling 183,489 shares during the quarter. Perpetual Ltd owned 0.48% of Afya worth $7,663,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of AFYA. Lifestyle Asset Management Inc. raised its position in Afya by 26.9% in the second quarter. Lifestyle Asset Management Inc. now owns 14,784 shares of the company's stock valued at $261,000 after purchasing an additional 3,133 shares during the period. Dodge & Cox grew its stake in shares of Afya by 7.0% in the fourth quarter. Dodge & Cox now owns 29,183 shares of the company's stock valued at $640,000 after buying an additional 1,900 shares in the last quarter. Cubist Systematic Strategies LLC raised its holdings in shares of Afya by 136.9% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 35,254 shares of the company's stock valued at $622,000 after buying an additional 20,370 shares during the period. Renaissance Technologies LLC lifted its stake in Afya by 19.7% during the 2nd quarter. Renaissance Technologies LLC now owns 266,500 shares of the company's stock worth $4,704,000 after acquiring an additional 43,800 shares in the last quarter. Finally, Millennium Management LLC boosted its holdings in Afya by 45.0% during the 2nd quarter. Millennium Management LLC now owns 291,164 shares of the company's stock valued at $5,139,000 after acquiring an additional 90,383 shares during the period. 88.02% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

AFYA has been the topic of a number of recent research reports. UBS Group started coverage on shares of Afya in a research note on Friday, August 30th. They set a "neutral" rating and a $19.50 price target on the stock. Morgan Stanley dropped their price objective on shares of Afya from $21.00 to $19.00 and set an "equal weight" rating for the company in a report on Friday, June 21st.

Get Our Latest Research Report on Afya

Afya Stock Up 1.6 %

NASDAQ:AFYA traded up $0.25 during midday trading on Friday, reaching $16.27. The company had a trading volume of 154,997 shares, compared to its average volume of 132,723. The stock's fifty day simple moving average is $17.02 and its 200-day simple moving average is $17.39. The company has a current ratio of 1.47, a quick ratio of 1.47 and a debt-to-equity ratio of 0.40. Afya Limited has a 12-month low of $14.64 and a 12-month high of $22.48. The firm has a market capitalization of $1.52 billion, a price-to-earnings ratio of 13.30, a PEG ratio of 0.45 and a beta of 0.92.

Afya (NASDAQ:AFYA - Get Free Report) last announced its quarterly earnings data on Thursday, August 15th. The company reported $0.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.06. Afya had a return on equity of 18.82% and a net margin of 18.12%. The business had revenue of $155.40 million during the quarter, compared to analysts' expectations of $151.83 million. On average, sell-side analysts anticipate that Afya Limited will post 1.52 earnings per share for the current fiscal year.

Afya Company Profile

(Free Report)

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.

Read More

Institutional Ownership by Quarter for Afya (NASDAQ:AFYA)

Should you invest $1,000 in Afya right now?

Before you consider Afya, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.

While Afya currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Post-Election Chaos or Opportunity? Prepare Your Investments
Strong Markets Meet Rising Volatility—Are Your Investments Safe?
Analysts Bullish on AI-Powered Healthcare: Intuitive Surgical’s 30% Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines